Functional analysis of cyclin D1 alternative transcript b
Functional analysis of cyclin D1 alternative transcript b
批准号:
10670980
负责人:
HOSOKAWA Yoshitaka
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
细胞周期蛋白D1/PRAD1癌基因是细胞周期G1期进程的关键调控因子,在伴有t(11;14)(q13;q32)易位的B细胞恶性肿瘤中被认为是长期寻找的bcl1癌基因。最近,我们发现了一种新的选择性剪接细胞周期蛋白D1转录本,称为转录本[b]。在几个人类非淋巴癌细胞系中,突变的转录本[b]的水平低于最初报道的Cyclin D1转录本,称为转录本[a],但转录本[b]产物的内源性细胞表达尚未确定。Northern印迹分析和逆转录聚合酶链式反应(RT-PCR)分析表明,转录产物[b]mRNAs在t(11;14)(q13;q32)易位的B淋巴样细胞系中有较好的表达,而在其他细胞中表达水平较低或检测不到。用人类细胞周期蛋白D1特异性的单抗进行免疫印迹分析,可以识别和区分转录本[a]和[b]的产物,强烈表明转录本[b]蛋白确实在这些B细胞系中表达。本研究首次鉴定了Cyclin D1转录本[b]蛋白的内源性细胞表达,并强烈提示Cyclin D1的这种替代形式可能在t(11;14)(q13;q32)易位的B淋巴系恶性肿瘤的分子发病机制中发挥重要作用。转录本[b]的生物学功能及其在细胞周期调控中的作用有待进一步研究。
英文摘要
The cyclin D1/PRAD1 oncogene, a key regulator of the G1 phase progression of the cell cycle has been identified as the long-sought BCL-1 oncogene in B-cell malignancies with t(11;14)(q13;q32) translocation. Recently, a novel alternative spliced cyclin D1 transcript, called transcript [b], has been identified by ourselves. The level of the variant transcript [b] was lower than that of the originally reported cyclin D1 transcript, called transcript [a], in several human non-lymphoid cancer cell lines but the endogenous cellular expression of transcript [b] products has not yet been determined. Northern blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed that the transcript [b] mRNAs are well expressed in B-lymphoid cell lines with t(11;14)(q13;q32) translocation and at much lower or undetectable levels in other cells. Western blot analysis using a human cyclin D1-specific monoclonal antibody, which can recognize and distinguish the products of transcripts [a] and [b], strongly suggested that the transcript [b] protein is indeed expressed in these B-cell lines. The present study provides the first identification of the endogenous cellular expression of the cyclin D1 transcript [b] protein and strongly suggests that this alternative form of cyclin D1 may play a significant role in the molecular pathogenesis of B-lymphoid malignancies with t(11;14)(q13;q32) translocation. Further studies are warranted to study the biological function of transcript [b] and its role in cell cycle control.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hosokawa, Y. et al.: "Cylin D1/PRAD1/BCL-1 alternative transcript[b]protein product in B-lymphoid malignancies with t(11 ; 14)(q13 ; q32) translocation"International Journal of Cancer. 81. 616-619 (1999)
Hosokawa, Y. 等人:“具有 t(11; 14)(q13; q32) 易位的 B 淋巴恶性肿瘤中的 Cylin D1/PRAD1/BCL-1 替代转录物 [b] 蛋白产物”国际癌症杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hosokawa Y, Joh T, Maeda Y, Arnold A, and Seto M.: "Cyclin D1/PRAD1/BCL-1 alternative transcript [b] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation."Int. J. Cancer.. 81. 616-619 (1999)
Hosokawa Y、Joh T、Maeda Y、Arnold A 和 Seto M.:“具有 t(11;14)(q13;q32) 的 B 淋巴恶性肿瘤中的细胞周期蛋白 D1/PRAD1/BCL-1 替代转录物 [b] 蛋白产物
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Joh, T. et al.: "Establishment of an inducible expression system of chimenric MLL-LTG9 protein and inhibition of Hox α7, Hox b7 and Hox c9 expression by MLL-LTG9"Oncogene. 18. 1125-1130 (1999)
Joh,T.等人:“嵌合MLL-LTG9蛋白诱导表达系统的建立以及MLL-LTG9对Hox α7、Hox b7和Hox c9表达的抑制”Oncogene.18.1125-1130(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Joh, T.et al.: "Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells." Oncogene,. 18. 1125-1130 (1999)
Joh, T. 等人:“建立了嵌合 MLL-LTG9 蛋白的诱导表达系统,并在 32Dcl3 细胞中通过 MLL-LTG9 抑制 Hox a7、Hox b7 和 Hox c9 的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Motegi, M., Yonequmi, M., Suzuki, H., suzuki, R., Hosokawa, Y., Hosaka, S., Kodera, Y., Morishima, M., Nakamura, S. and Seto, M.: "API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogenous products."A
Motegi, M.、Yonequmi, M.、Suzuki, H.、suzuki, R.、Hosokawa, Y.、Hosaka, S.、Kodera, Y.、Morishima, M.、Nakamura, S. 和 Seto, M.:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Basic study of the bioactive substances of a skin of citrus fruits for periodontal disease treatment
-
批准号:19K10151
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2019
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of leukocyte infiltration mechanism to participate in inflammatory bone resorption in periodontal lesion
-
批准号:16K11834
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2016
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of Th17 cells migration and activation in periodontally diseased tissues
-
批准号:25463219
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2013
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of Th17 cells migration inperiodontally diseased tissues.
-
批准号:23792479
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2011
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of Th17 cells migration and activation in periodontally diseased tissues.
-
批准号:21792123
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Molecular analysis of anti-apoptotic action in MALT lymphoma and its clinical application for diagnosis and treatment.
-
批准号:17591023
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Molecular analysis of malignant lymphoma-related oncogenes and its clinical application for diagnosis and treatment.
-
批准号:15591034
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Molecular analysis of B-cell malignant lymphoma-related oncogenes and its clinical application for diagnosis and treatment.
-
批准号:13671091
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2001
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
海外基金